313 related articles for article (PubMed ID: 15016878)
1. The vaccinia virus K1L gene product inhibits host NF-kappaB activation by preventing IkappaBalpha degradation.
Shisler JL; Jin XL
J Virol; 2004 Apr; 78(7):3553-60. PubMed ID: 15016878
[TBL] [Abstract][Full Text] [Related]
2. Stable expression of the vaccinia virus K1L gene in rabbit cells complements the host range defect of a vaccinia virus mutant.
Sutter G; Ramsey-Ewing A; Rosales R; Moss B
J Virol; 1994 Jul; 68(7):4109-16. PubMed ID: 8207789
[TBL] [Abstract][Full Text] [Related]
3. Poxviral regulation of the host NF-kappaB response: the vaccinia virus M2L protein inhibits induction of NF-kappaB activation via an ERK2 pathway in virus-infected human embryonic kidney cells.
Gedey R; Jin XL; Hinthong O; Shisler JL
J Virol; 2006 Sep; 80(17):8676-85. PubMed ID: 16912315
[TBL] [Abstract][Full Text] [Related]
4. The ORF61 Protein Encoded by Simian Varicella Virus and Varicella-Zoster Virus Inhibits NF-κB Signaling by Interfering with IκBα Degradation.
Whitmer T; Malouli D; Uebelhoer LS; DeFilippis VR; Früh K; Verweij MC
J Virol; 2015 Sep; 89(17):8687-700. PubMed ID: 26085158
[TBL] [Abstract][Full Text] [Related]
5. Cowpox virus and other members of the orthopoxvirus genus interfere with the regulation of NF-kappaB activation.
Oie KL; Pickup DJ
Virology; 2001 Sep; 288(1):175-87. PubMed ID: 11543670
[TBL] [Abstract][Full Text] [Related]
6. Functional F11L and K1L genes in modified vaccinia virus Ankara restore virus-induced cell motility but not growth in human and murine cells.
Zwilling J; Sliva K; Schwantes A; Schnierle B; Sutter G
Virology; 2010 Sep; 404(2):231-9. PubMed ID: 20627347
[TBL] [Abstract][Full Text] [Related]
7. Characterization of wild-type and mutant vaccinia virus M2L proteins' abilities to localize to the endoplasmic reticulum and to inhibit NF-kappaB activation during infection.
Hinthong O; Jin XL; Shisler JL
Virology; 2008 Apr; 373(2):248-62. PubMed ID: 18190944
[TBL] [Abstract][Full Text] [Related]
8. Vaccinia virus infection attenuates innate immune responses and antigen presentation by epidermal dendritic cells.
Deng L; Dai P; Ding W; Granstein RD; Shuman S
J Virol; 2006 Oct; 80(20):9977-87. PubMed ID: 17005676
[TBL] [Abstract][Full Text] [Related]
9. Modified vaccinia virus Ankara can activate NF-kappaB transcription factors through a double-stranded RNA-activated protein kinase (PKR)-dependent pathway during the early phase of virus replication.
Lynch HE; Ray CA; Oie KL; Pollara JJ; Petty IT; Sadler AJ; Williams BR; Pickup DJ
Virology; 2009 Sep; 391(2):177-86. PubMed ID: 19596385
[TBL] [Abstract][Full Text] [Related]
10. Viral host-range factor C7 or K1 is essential for modified vaccinia virus Ankara late gene expression in human and murine cells, irrespective of their capacity to inhibit protein kinase R-mediated phosphorylation of eukaryotic translation initiation factor 2alpha.
Backes S; Sperling KM; Zwilling J; Gasteiger G; Ludwig H; Kremmer E; Schwantes A; Staib C; Sutter G
J Gen Virol; 2010 Feb; 91(Pt 2):470-82. PubMed ID: 19846675
[TBL] [Abstract][Full Text] [Related]
11. Transient host range selection for genetic engineering of modified vaccinia virus Ankara.
Staib C; Drexler I; Ohlmann M; Wintersperger S; Erfle V; Sutter G
Biotechniques; 2000 Jun; 28(6):1137-42, 1144-6, 1148. PubMed ID: 10868279
[TBL] [Abstract][Full Text] [Related]
12. Characterizing the effects of insertion of a 5.2 kb region of a VACV genome, which contains known immune evasion genes, on MVA immunogenicity.
Ryerson MR; Shisler JL
Virus Res; 2018 Feb; 246():55-64. PubMed ID: 29341877
[TBL] [Abstract][Full Text] [Related]
13. Replication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L.
Hornemann S; Harlin O; Staib C; Kisling S; Erfle V; Kaspers B; Häcker G; Sutter G
J Virol; 2003 Aug; 77(15):8394-407. PubMed ID: 12857909
[TBL] [Abstract][Full Text] [Related]
14. The C11R gene, which encodes the vaccinia virus growth factor, is partially responsible for MVA-induced NF-κB and ERK2 activation.
Martin S; Harris DT; Shisler J
J Virol; 2012 Sep; 86(18):9629-39. PubMed ID: 22740414
[TBL] [Abstract][Full Text] [Related]
15. Complementation of a vaccinia virus host-range K1L gene deletion by the nonhomologous CP77 gene.
Ramsey-Ewing AL; Moss B
Virology; 1996 Aug; 222(1):75-86. PubMed ID: 8806489
[TBL] [Abstract][Full Text] [Related]
16. Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence.
Meyer H; Sutter G; Mayr A
J Gen Virol; 1991 May; 72 ( Pt 5)():1031-8. PubMed ID: 2033387
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo study of the ectromelia virus homolog of the vaccinia virus K1L host range gene.
Chen W; Drillien R; Spehner D; Buller RM
Virology; 1993 Oct; 196(2):682-93. PubMed ID: 8372441
[TBL] [Abstract][Full Text] [Related]
18. Vaccinia virus K1 ankyrin repeat protein inhibits NF-κB activation by preventing RelA acetylation.
Bravo Cruz AG; Shisler JL
J Gen Virol; 2016 Oct; 97(10):2691-2702. PubMed ID: 27503790
[TBL] [Abstract][Full Text] [Related]
19. Role of viral factor E3L in modified vaccinia virus ankara infection of human HeLa Cells: regulation of the virus life cycle and identification of differentially expressed host genes.
Ludwig H; Mages J; Staib C; Lehmann MH; Lang R; Sutter G
J Virol; 2005 Feb; 79(4):2584-96. PubMed ID: 15681458
[TBL] [Abstract][Full Text] [Related]
20. Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line.
Carroll MW; Moss B
Virology; 1997 Nov; 238(2):198-211. PubMed ID: 9400593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
